Latest filing published 24 May 2017 for AstraZeneca PLC, €606k.
Filing timeline
BuySaleInsider track record
No signal scores available.
Mark Mallon: trading record in brief
Mark Mallon appears in our data through filings on AstraZeneca PLC shares, published by Finansinspektionen. We count 2 filings; the first trade dates from 28 March 2017 and the latest from 23 May 2017.
No open-market purchase appears, only 1 sale worth €606k. The rest of the record consists of 1 share grant.
The latest filing, published on 24 May 2017, reports an open-market sale of €606k in AstraZeneca PLC. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by Finansinspektionen and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Mark Mallon
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 20,000 shares@ US$33.9002100.0% of flowNYSEFCA-NSM:LSE20170524150002_13237397_20200330131531370_19516
- 22,620 sharesOutside a trading venueFCA-NSM:LSE20170328160002_13174529_20200330131526730_22655-2
2 of 2 declarations
